Published on September 25, 2023 at 9:50 p.m. Modified on September 25, 2023 at 11:36 p.m.
On September 20, a new stage was recorded in the history of xenotransplantation (when an animal organ is transplanted into the human body). With his consent, a 58-year-old man suffering from end-stage cardiovascular disease received a heart taken from a genetically modified pig by surgeons in the United States. This patient is the second in whom this type of intervention has been attempted, after a first historic trial in January 2022 in a 57-year-old man, David Bennett, carried out by the same scientific and medical team. The latter died two months after the porcine heart transplant.
Preparing the pig heart for transplantation into patient Lawrence Faucette, September 20, 2023 in Baltimore. — © Mark Teske/University of Maryland School of Medicine
Interested in this item?
Don’t miss any of our content published daily – subscribe now from 9.- CHF for the first month to access all our articles, files, and analyses.
CHECK OFFERS Good reasons to subscribe to Le Temps: Consult all the unlimited content on the site and the mobile application Access the paper edition in digital version before 7 a.m. Benefit from exclusive privileges reserved for subscribers Access the archives
Already a subscriber? To log in
2023-09-25 19:50:24
#pigs #heart #transplanted #patient #United #States #time #Temps
